Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Bilobalide
75
CHF
CHF 75.00
In stock
AG-CN2-0026-M01010 mgCHF 75.00
AG-CN2-0026-M05050 mgCHF 300.00
Product Details | |
---|---|
Product Type | Chemical |
Properties | |
Formula |
C15H18O8 |
MW | 326.3 |
Merck Index | 14: 1220 |
CAS | 33570-04-6 |
Source/Host Chemicals | Isolated from Ginko biloba. |
Purity Chemicals | ≥95% (1H-NMR) |
Appearance | White solid. |
Solubility | Soluble in ethanol or DMSO. |
Identity | Determined by 1H-NMR. |
InChi Key | MOLPUWBMSBJXER-ISSLQHLCSA-N |
Smiles | CC(C)(C)[C@]1(O)C[C@@H]2OC(=O)C[C@@]22C(=O)O[C@@H]3OC(=O)[C@H](O)C123 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability |
Stable for at least 2 years after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Neuroprotective [2, 3, 4, 5, 7].
- Mitochondrial gene expression regulator [3].
- ROS scavenger [4].
- Competitive GABA(A) receptor antagonist [6].
- Apoptosis inhibitor [4, 7, 10, 11].
- CREB phosphorylation enhancer. Stimulates neurogenesis and synaptogenesis [8].
- Hepatic cytochrome P450 inducer [9].
- Activates the phosphatidylinositol 3-kinase (PI3K) dependent pathway [10, 11].
- Potent anti-inflammatory and antihyperalgesic agent [12].
Product References
- Bilobalid A, ein neues Sesquiterpen mit tert.-Butyl-Gruppe aus den Blättern von Ginkgo biloba L.: K. Weinges & W. Bähr; Liebigs Ann. Chem. 724, 214 (1969)
- Protection of hypoxia-induced ATP decrease in endothelial cells by ginkgo biloba extract and bilobalide: D. Janssens, et al.; Biochem. Pharmacol. 50, 991 (1995)
- Protection of mitochondrial respiration activity by bilobalide: D. Janssens, et al.; Biochem. Pharmacol. 58, 109 (1999)
- Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide: L.J. Zhou & X.Z. Zhu; J. Pharmacol. Exp. Ther. 293, 982 (2000)
- Bilobalide and neuroprotection: F.V. Defeudis; Pharmacol. Res. 46, 565 (2002) (Review)
- Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA(A) receptors: S.H. Huang, et al.; Eur. J. Pharmacol. 464, 1 (2003)
- Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death: K. Chandrasekaran, et al.; Pharmacopsychiatry 36 Suppl 1, S89 (2003)
- Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons: F. Tchantchou, et al.; J. Alzheimers Dis. 18, 787 (2009)
- Time-dependent induction of hepatic cytochrome P450 enzyme activity and mRNA expression by bilobalide in rats: Y. Taki, et al.; J. Pharmacol. Sci. 109, 459 (2009)
- Bilobalide prevents apoptosis through activation of the PI3K/Akt pathway in SH-SY5Y cells: C. Shi, et al.; Apoptosis 15, 715 (2010)
- Bilobalide regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway: C. Shi, et al.; Neurochem. Int. 59, 59 (2011)
- Bilobalide, a unique constituent of Ginkgo biloba, inhibits inflammatory pain in rats: M. Goldie & S. Dolan; Behav. Pharmacol. 24, 298 (2013)